1997
DOI: 10.1111/j.1600-0676.1997.tb00797.x
|View full text |Cite
|
Sign up to set email alerts
|

The relationship of histology to genotype in chronic HCV infection

Abstract: Booth JCL, Foster GR, Levine T, Thomas HC, Goldin RD. The relationship of histology to genotype in chronic HCV infection.Abstract: The histological description of chronic hepatitis is undergoing considerable change at present. It has become important to define chronic hepatitis aetiologically and then define levels of necro-inflanmatory change (grade) and fibrosis (stage). The aim of this study was to compare the ability of different histological scoring systems to detect differences in the pathological change… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
1

Year Published

1998
1998
2015
2015

Publication Types

Select...
6
1

Relationship

0
7

Authors

Journals

citations
Cited by 21 publications
(2 citation statements)
references
References 39 publications
(27 reference statements)
0
1
1
Order By: Relevance
“…The clinical significance of genotyping is still under investigation 3,11,28 , and in this study, unlike previous studies, there was no correlation between HVC genotypes and the CD4+ or CD8+ TL expression in the liver 32,34 , possibly because of the small number of genotypes 2 and 3 in this sample.…”
Section: Discussioncontrasting
confidence: 72%
“…The clinical significance of genotyping is still under investigation 3,11,28 , and in this study, unlike previous studies, there was no correlation between HVC genotypes and the CD4+ or CD8+ TL expression in the liver 32,34 , possibly because of the small number of genotypes 2 and 3 in this sample.…”
Section: Discussioncontrasting
confidence: 72%
“…King's Score: an accurate marker of cirrhosis in chronic hepatitis C Introduction Liver biopsy (LB) is considered the 'gold standard' for assessing the grade of necroinflammatory activity and stage of liver fibrosis in chronic hepatitis C. Historically, patients were considered to be candidates for combination therapy with peginterferon-a and ribavirin if they had moderate to severe disease, defined by histological evidence of significant fibrosis and/or inflammation [1,2]. Risks, however, associated with LB including pain, bleeding and death [3] are observed.…”
mentioning
confidence: 99%